EUVIMEDEUVIMED entdecken
Crossref

Aspalathin, a Primary Rooibos Flavonoid, Alleviates Mast Cell-Mediated Allergic Inflammation by the Inhibition of FcεRI Signaling Pathway

Yeyoung Kim, Soyoung Lee, Meiling Jin, Young-Ae Choi, Jin Kyeong Choi, Taeg Kyu Kwon, Dongwoo Khang, Sang-Hyun Kim

Inflammation · 2024

DOI: 10.1007/s10753-024-02034-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammation, 2024. Verfasst von Yeyoung Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Medicine, CMRI, Kyungpook National University, Daegu, 41944, Republic of Korea. Hauptthemen laut MEDLINE: Mast Cells, Signal Transduction, Receptors, IgE, Chalcones. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Research Foundation of Korea, Ministry of Trade, Industry and Energy, 한국연구재단 , 대한민국.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mast cells are primary cells initiating allergic inflammation by the release of various allergic mediators, such as histamine and pro-inflammatory cytokines. Aspalathin (ASP) is the predominant flavonoid found exclusively in rooibos, an herb that has been traditionally used in allergy relief therapy. In the present study, we investigated the beneficial effects of ASP on mast cell-mediated allergic inflammation. For in vivo study, two well-known mast cell-mediated local and systemic allergic inflammation mouse models were used: passive cutaneous anaphylaxis (PCA) and active systemic anaphylaxis mouse models (ASA). Oral administration of ASP dose-dependently suppressed immunoglobulin (Ig)E-mediated PCA responses evidenced by Evans blue extravasation, ear thickening, and mast cell degranulation. ASP also significantly mitigated ovalbumin-induced ASA responses, including hypothermia, histamine secretion, and the production of IgE and interleukin-4. Notably, ASP was more effective in suppressing allergic inflammation than nothofagin, another prominent flavonoid known as an anti-allergic component of rooibos. The regulatory mechanism of mast cell activation by ASP was clarified using mast cell line and primary cultured mast cells (RBL-2H3 and mouse bone marrow-derived mast cells). ASP reduced IgE-stimulated mast cells degranulation and intracellular calcium influx by the inhibition of FcεRI signaling pathway (Lyn, Fyn, and Syk). Moreover, ASP reduced pro-inflammatory cytokine expressions by inhibiting two major transcription factors, nuclear factor of activated T cells and nuclear factor-κB. Collectively, we proposed that ASP could be a potential therapeutic candidate for the treatment of mast cell-mediated allergic inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mast CellsSignal TransductionReceptors, IgEChalconesInflammationFlavonoidsHypersensitivityAnimalsMicePassive Cutaneous AnaphylaxisCell DegranulationAnaphylaxisAnti-Allergic AgentsMice, Inbred BALB CMaleImmunoglobulin E

Stichwörter der Autor:innen

Allergic inflammationAspalathinHistamineMast cells

Substanzen

Receptors, IgEChalconesFlavonoidsAnti-Allergic AgentsImmunoglobulin E

Autor:innen und Institutionen

  • Department of Pharmacology, School of Medicine, CMRI, Kyungpook National University, Daegu, 41944, Republic of Korea.
  • Immunoregulatory Materials Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup, 56212, Republic of Korea.
  • Department of Pharmacology, School of Medicine, Yanbian National University, Yanji, 133001, China.
  • Department of Immunology, Jeonbuk National University Medical School, Jeonju, 54896, Republic of Korea.
  • Department of Immunology, School of Medicine, Keimyung University, Daegu, 42601, Republic of Korea.
  • Department of Physiology, School of Medicine, Gachon University, Incheon, 21999, Republic of Korea. dkhang@gachon.ac.kr.

Förderung

  • National Research Foundation of Korea
  • Ministry of Trade, Industry and Energy
  • 한국연구재단 , 대한민국

Zitieren

APA

Kim, Y., Lee, S., Jin, M., Choi, Y. A., Choi, J. K., Kwon, T. K., Khang, D., & Kim, S. H. (2024). Aspalathin, a Primary Rooibos Flavonoid, Alleviates Mast Cell-Mediated Allergic Inflammation by the Inhibition of FcεRI Signaling Pathway. Inflammation. https://doi.org/10.1007/s10753-024-02034-1

Vancouver

Kim Y, Lee S, Jin M, Choi YA, Choi JK, Kwon TK, et al. Aspalathin, a Primary Rooibos Flavonoid, Alleviates Mast Cell-Mediated Allergic Inflammation by the Inhibition of FcεRI Signaling Pathway. Inflammation. 2024. doi:10.1007/s10753-024-02034-1

BibTeX
@article{Kim2024,
  author = {Kim, Yeyoung and Lee, Soyoung and Jin, Meiling and Choi, Young-Ae and Choi, Jin Kyeong and Kwon, Taeg Kyu and Khang, Dongwoo and Kim, Sang-Hyun},
  title = {Aspalathin, a Primary Rooibos Flavonoid, Alleviates Mast Cell-Mediated Allergic Inflammation by the Inhibition of FcεRI Signaling Pathway},
  journal = {Inflammation},
  year = {2024},
  doi = {10.1007/s10753-024-02034-1}
}
Kostenlos starten →